|
May 28
|
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
|
|
May 24
|
Is There An Opportunity With InMode Ltd.'s (NASDAQ:INMD) 35% Undervaluation?
|
|
May 23
|
Do Options Traders Know Something About InMode Stock We Don't?
|
|
Apr 14
|
InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M
|
|
Apr 10
|
InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?
|
|
Apr 4
|
Why InMode Ltd. (NASDAQ:INMD) Could Be Worth Watching
|
|
Jan 20
|
InMode (NASDAQ:INMD) earnings and shareholder returns have been trending downwards for the last three years, but the stock rallies 5.1% this past week
|
|
Dec 30
|
With 57% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big guns
|
|
Sep 26
|
Should Value Investors Buy InMode (INMD) Stock?
|
|
Sep 23
|
InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now
|
|
Sep 4
|
InMode to Present at 2024 Baird Global Healthcare Conference
|
|
Sep 2
|
InMode (INMD): The Best Middle East and Africa Stocks to Buy According to Analysts?
|
|
Aug 14
|
InMode Ltd. (INMD): Challenges and Insights in the Beauty Industry
|
|
Aug 3
|
InMode Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
|
|
Aug 2
|
InMode (INMD) Q2 2024 Earnings Call Transcript
|
|
Aug 1
|
Investing in InMode (NASDAQ:INMD) five years ago would have delivered you a 167% gain
|
|
Aug 1
|
InMode (INMD) Q2 Earnings and Revenues Top Estimates
|
|
Aug 1
|
InMode: Q2 Earnings Snapshot
|
|
Aug 1
|
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M
|
|
Jul 31
|
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
|